1:11-cv-02340 | Shire LLC v. Watson Pharmaceuticals, Inc. et al | Apr 5, 2011 |
3:13-cv-01452 | Shire LLC v. Neos Therapeutics, Inc. | Apr 11, 2013 |
1:14-cv-05694 | SHIRE LLC v. COREPHARMA, LLC | Sep 12, 2014 |
1:14-cv-06095 | SHIRE LLC v. AMERIGEN PHARMACEUTICALS LIMITED | Oct 1, 2014 |
1:15-cv-01454 | SHIRE LLC v. PAR PHARMACEUTICAL, INC. et al | Feb 26, 2015 |
IPR2015-02009 | Amerigen Pharmaceuticals Limited v. Shire LLC,Shire US Inc., Shire Development LLC, and Shire Plc. | Oct 1, 2015 |
1:15-cv-13909 | Shire LLC et al v. Abhai LLC | Nov 20, 2015 |
IPR2016-01033 | Mylan Pharmaceuticals Inc. et al. v. Shire Laboratories, Inc. and Shire LLC | May 12, 2016 |
IPR2017-00011 | Mylan Pharmaceuticals Inc. v. Shire Laboratory Inc . | Oct 4, 2016 |
1:17-cv-01696 | Shire Development LLC et al v. Teva Pharmaceuticals USA, Inc. et al | Nov 22, 2017 |
1:17-cv-01840 | Shire Development LLC et al v. Rhodes Pharmaceuticals L.P. | Dec 21, 2017 |
1:18-cv-00549 | Shire Development LLC et al v. Impax Laboratories LLC | Apr 13, 2018 |
1:18-cv-00800 | Shire Development LLC et al v. SpecGx LLC | May 25, 2018 |